文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

奥密克戎变异株的融合性和致病性减弱。

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.

机构信息

Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

出版信息

Nature. 2022 Mar;603(7902):700-705. doi: 10.1038/s41586-022-04462-1. Epub 2022 Feb 1.


DOI:10.1038/s41586-022-04462-1
PMID:35104835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8942852/
Abstract

The emergence of the Omicron variant of SARS-CoV-2 is an urgent global health concern. In this study, our statistical modelling suggests that Omicron has spread more rapidly than the Delta variant in several countries including South Africa. Cell culture experiments showed Omicron to be less fusogenic than Delta and than an ancestral strain of SARS-CoV-2. Although the spike (S) protein of Delta is efficiently cleaved into two subunits, which facilitates cell-cell fusion, the Omicron S protein was less efficiently cleaved compared to the S proteins of Delta and ancestral SARS-CoV-2. Furthermore, in a hamster model, Omicron showed decreased lung infectivity and was less pathogenic compared to Delta and ancestral SARS-CoV-2. Our multiscale investigations reveal the virological characteristics of Omicron, including rapid growth in the human population, lower fusogenicity and attenuated pathogenicity.

摘要

新冠病毒(SARS-CoV-2)奥密克戎变异株的出现是一个紧迫的全球卫生关切。在本研究中,我们的统计模型表明,奥密克戎在包括南非在内的几个国家的传播速度比德尔塔变异株更快。细胞培养实验表明,奥密克戎的融合性低于德尔塔和新冠病毒原始株。虽然德尔塔的刺突(S)蛋白可有效地切割成两个亚单位,从而促进细胞间融合,但与德尔塔和原始 SARS-CoV-2 的 S 蛋白相比,奥密克戎 S 蛋白的切割效率较低。此外,在仓鼠模型中,奥密克戎与德尔塔和原始 SARS-CoV-2 相比,肺部感染性降低,致病性减弱。我们的多尺度研究揭示了奥密克戎的病毒学特征,包括在人群中的快速增长、较低的融合性和减弱的致病性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/d792d6d5b0e8/41586_2022_4462_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/f86979d9459d/41586_2022_4462_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/4cb52e854452/41586_2022_4462_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/7994e08c48c1/41586_2022_4462_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/7ef24c1cf8a4/41586_2022_4462_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/aaa7b976436b/41586_2022_4462_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/55ea23a91af3/41586_2022_4462_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/8d9e3407144d/41586_2022_4462_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/717042a58fa4/41586_2022_4462_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/210624e01e41/41586_2022_4462_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/4dac67292fe0/41586_2022_4462_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/0a951ca8ef10/41586_2022_4462_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/29ba88395a3b/41586_2022_4462_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/d792d6d5b0e8/41586_2022_4462_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/f86979d9459d/41586_2022_4462_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/4cb52e854452/41586_2022_4462_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/7994e08c48c1/41586_2022_4462_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/7ef24c1cf8a4/41586_2022_4462_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/aaa7b976436b/41586_2022_4462_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/55ea23a91af3/41586_2022_4462_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/8d9e3407144d/41586_2022_4462_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/717042a58fa4/41586_2022_4462_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/210624e01e41/41586_2022_4462_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/4dac67292fe0/41586_2022_4462_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/0a951ca8ef10/41586_2022_4462_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/29ba88395a3b/41586_2022_4462_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42e0/8942852/d792d6d5b0e8/41586_2022_4462_Fig13_ESM.jpg

相似文献

[1]
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.

Nature. 2022-3

[2]
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.

Nature. 2022-3

[3]
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.

Nature. 2022-2

[4]
The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.

J Virol. 2024-3-19

[5]
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation.

Nature. 2023-3

[6]
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.

Cell. 2022-6-9

[7]
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.

Nature. 2022-3

[8]
Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.

J Med Virol. 2022-4

[9]
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.

J Virol. 2022-9-14

[10]
SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells.

Viruses. 2024-4-19

引用本文的文献

[1]
A fusion ORF3a-E subgenomic RNA involved in SARS-CoV-2 infection efficacy by influencing cellular protein synthesis.

Front Immunol. 2025-8-15

[2]
Single-cell transcriptomic atlas of blood and lung from mice infected with SARS-CoV-2 revealing distinct virulence characteristics between prototype and Omicron BA.1 strain.

Virulence. 2025-12

[3]
Pathogen virulence genes: Advances, challenges and future directions in infectious disease research (Review).

Int J Mol Med. 2025-11

[4]
Analysis on effectiveness of subway epidemic prevention measures considering subway passenger flow.

Front Public Health. 2025-8-1

[5]
Revisiting awake prone positioning in COVID-19.

Ann Intensive Care. 2025-8-6

[6]
Penetration of SARS-CoV-2 Alpha, Delta, and Omicron variants in the United States.

Epidemiol Infect. 2025-8-4

[7]
Cross-neutralization ability of anti-MERS-CoV monoclonal antibodies against a variety of merbecoviruses.

Front Microbiol. 2025-7-16

[8]
The P132H mutation of SARS-CoV-2 NSP5 relieves its inhibition on interferon-β activation via blocking MAVS degradation.

Cell Mol Life Sci. 2025-7-30

[9]
Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial.

Viruses. 2025-7-14

[10]
The characteristic change of autoimmune encephalitis after the COVID-19 epidemic in Guangxi, China.

Sci Rep. 2025-7-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索